Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 11NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 18Prostatic Neoplasms 15Neoplasms 12Multiple Myeloma 11Carcinoma, Non-Small-Cell Lung 11Melanoma 9Pancreatic Neoplasms 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma 6Leukemia, Myeloid, Acute 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lung Neoplasms 5Hodgkin Disease 5Sarcoma 4Ovarian Neoplasms 4Osteosarcoma 4Hematologic Neoplasms 4Brain Neoplasms 4Teratoma 3Smoldering Multiple Myeloma 3Small Cell Lung Carcinoma 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Neoplasm Metastasis 3Malignant Solid Neoplasm 3HIV Infections 3Fallopian Tube Neoplasms 3Colonic Neoplasms 3

Interventions

pembrolizumab 1Taxes 1Surgical Procedures, Operative 1Specimen Handling 1Paclitaxel 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × NETWORK × Anatomic Stage I Breast Cancer AJCC v8 × Clear all
NCT05929768 2025-11-05

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

SWOG Cancer Research Network

Phase 3 Recruiting
2,400 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡